Integrated Genomic and Metabolomic Profiles in Newborn Infants
新生儿的综合基因组和代谢组图谱
基本信息
- 批准号:8582157
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-20 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAreaAwardBiochemicalBiologicalBiological AssayBiological MarkersBloodClinicalClinical SciencesCollectionCommunicable DiseasesComplexConsultCoronary heart diseaseCystic FibrosisDNADataData Storage and RetrievalDatabasesDevelopmentDevelopment PlansDiseaseDizygotic TwinsElementsEnvironmentEnvironmental Risk FactorEnzymesEpidemiologyEtiologyFacultyFluorescenceFundingGenderGeneticGenetic PolymorphismGenomicsGenotypeGestational AgeGoalsHemoglobinopathiesHereditary DiseaseHeritabilityInborn Errors of MetabolismInborn Genetic DiseasesIndividualInfantInstitutesIowaKnowledgeLearningLipidsLow Birth Weight InfantMass Spectrum AnalysisMeasurementMedicineMentorsMetabolicModelingMonozygotic TwinningMonozygotic twinsNeonatalNeonatal ScreeningNewborn InfantOutcome MeasurePathway interactionsPerinatalPerinatal DisorderPhasePremature BirthPublic HealthResearchResourcesRiskScientistScreening ResultSpottingsStudentsStudy modelsSubjects SelectionsTechniquesTestingTrainingTranslational ResearchTwin Multiple BirthUniversitiesVariantWorkanalytical methodcareercareer developmentcollegecytokinedisorder riskendophenotypeexperiencegenetic epidemiologygenetic variantgenome wide association studyhuman diseaseinnovationmeetingsmembermetabolomicsprematureprofessorprogramsrepositoryreproductiveresearch studyscreeningskillsstatisticssymposiumtandem mass spectrometrytool
项目摘要
PROJECT SUMMARY
Candidate: Dr. Kelli Ryckman is a Postdoctoral Research Fellow for the Carver College of Medicine at the
University of Iowa. Her primary research focus is on the genetics and epidemiology of complex reproductive
disorders including preterm birth and related complications. Her short-term career goals are to enhance her
knowledge of the genetics of complex reproductive and perinatal conditions in newborns and to gain additional
skills in analytical methods and techniques for elucidating risks of complex diseases. Her long-term goals are
to become a funded independent scientist in the fields of genetics, statistics and epidemiology as tenure-track
faculty at a University. Her research plan is innovative in combining genomic and metabolomic profiles to
understand complex disease risks. This research will utilize the Iowa Newborn Metabolic Screening Program
(INMSP) where a deep resource of phenotypic, environmental and genetic components is available. This
research has the potential to identify new biological pathways involved in neonatal disease and to have direct
clinical impact on universal newborn screening programs. Mentors and Consultants: Dr. Jeff Murray will serve
as primary mentor on this award. He is a well-funded full professor at the University of Iowa with 25 years of
experience in training successful graduate and postdoctoral students. Dr. Mary Marazita, an expert in the field
of statistical genetics, will serve as co-mentor of this award. Drs. Stanton Berberich and Kristi Borowski will
serve as consultants on this project by providing clinical and statistical genetic expertise. Drs. Sara Copeland,
John Dagle and Jonathan Haines will serve as external advisory members and will consult with, advise and
evaluate the progress of Dr. Ryckman throughout the award period and have complementary expertise in the
metabolomics of the neonatal biochemical milieu, the complications of preterm birth and genomic analysis.
Environment: The University of Iowa has an established reputation for the successful training of graduate and
postdoctoral students, particularly in research and clinical areas. The University offers a range of learning and
development seminars as well as other programs focused on career development and advancement and
particularly benefits from training opportunities deriving from its ICTS (Institute for Clinical and Translational
Sciences) support by a CTSA award. Career Development Plan: Dr. Ryckman plans to meet regularly with her
mentors, consultants and external advisory members to gain the knowledge necessary to obtain her career
and research goals as well as attending tutorials, courses, seminars and relevant conferences. Research
Study: The focus of this study is to use the Iowa newborn screening data as a model for studying the
metabolomic and genomic profiles of newborns and relate the profiles to human disease, particularly
prematurity and its complications.
项目摘要
候选人:Kelli Ryckman博士是卡弗医学院的博士后研究员,
爱荷华州大学。她的主要研究重点是复杂生殖系统疾病的遗传学和流行病学。
包括早产和相关并发症在内的疾病。她的短期职业目标是提高她的
了解新生儿复杂的生殖和围产期疾病的遗传学知识,并获得额外的
掌握分析方法和技术,以阐明复杂疾病的风险。她的长期目标是
成为遗传学,统计学和流行病学领域的独立科学家,
在一所大学任教。她的研究计划在结合基因组学和代谢组学方面具有创新性,
了解复杂的疾病风险。这项研究将利用爱荷华州新生儿代谢筛查计划
(INMSP),其中表型,环境和遗传成分的深层资源可用。这
研究有可能确定新生儿疾病所涉及的新的生物学途径,
对普遍新生儿筛查计划的临床影响。导师和顾问:杰夫·默里博士将担任
作为这个奖项的主要导师他是爱荷华州大学资金充足的正教授,
培养成功的研究生和博士后学生的经验。玛丽玛拉兹塔博士,这方面的专家
统计遗传学博士将担任该奖项的共同导师。Stanton Berberich博士和Kristi Borowski博士将
通过提供临床和统计遗传学专业知识,担任该项目的顾问。莎拉·科普兰医生
John Dagle和Jonathan Haines将担任外部顾问成员,并将与
在整个授予期间评估Ryckman博士的进展,并在
新生儿生化环境的代谢组学、早产并发症和基因组分析。
环境:爱荷华州大学在成功培养研究生和
博士后学生,特别是在研究和临床领域。大学提供一系列的学习和
发展研讨会以及其他侧重于职业发展和进步的方案,
特别受益于ICTS(临床和翻译研究所)提供的培训机会
科学)由CTSA奖支持。职业发展计划:Ryckman博士计划定期与她会面
导师,顾问和外部咨询成员,以获得必要的知识,以获得她的职业生涯
和研究目标,以及参加辅导,课程,研讨会和相关会议。研究
研究:本研究的重点是使用爱荷华州的新生儿筛查数据作为研究
新生儿的代谢组学和基因组谱,并将谱与人类疾病,特别是
早产及其并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KELLI K. RYCKMAN其他文献
KELLI K. RYCKMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KELLI K. RYCKMAN', 18)}}的其他基金
Integrated Genomic and Metabolomic Profiles in Newborn Infants
新生儿的综合基因组和代谢组图谱
- 批准号:
8619646 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Integrated Genomic and Metabolomic Profiles in Newborn Infants
新生儿的综合基因组和代谢组图谱
- 批准号:
8131762 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Integrated Genomic and Metabolomic Profiles in Newborn Infants
新生儿的综合基因组和代谢组图谱
- 批准号:
7952511 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: